JDS Therapeutics sells Nutrition21 to Everwell

JDS Therapeutics has sold its specialty ingredient subsidiary, Nutrition21, to Everwell Health Holdings, which is backed by RoundTable Healthcare Partners.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this